- 专利标题： Cancer treatment with c-met antagonists and correlation of the latter with HGF expression
-
申请号： US15272283申请日： 2016-09-21
-
公开(公告)号： US10240207B2公开(公告)日： 2019-03-26
- 发明人: Wei Yu , David Shames , Hartmut Koeppen , See Phan , Sandra Rost
- 申请人： Genentech, Inc.
- 申请人地址： US CA South San Francisco
- 专利权人： Genentech, Inc.
- 当前专利权人： Genentech, Inc.
- 当前专利权人地址： US CA South San Francisco
- 代理机构： Morrison & Foerster LLP
- 主分类号： C12Q1/6886
- IPC分类号： C12Q1/6886 ; C07K16/22 ; C07K16/28 ; A61K39/00
摘要：
The present invention concerns cancer biomarkers. In particular, the invention concerns HGF as a biomarker for patient selection and patient prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
公开/授权文献
信息查询
IPC分类:
